Catalyst

Slingshot members are tracking this event:

Inovio Pharma (INO) signs collaborative research agreements (CRAs) with the Wistar Institute for preventive and therapeutic DNA-based immunotherapy applications

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
INO

100%

Additional Information

Additional Relevant Details Prior to his recent move to Wistar, the underlying technology for Inovio’s DNA-based products was first developed at Dr. Weiner’s UPenn laboratory. Inovio’s license agreements for intellectual property developed at the University of Pennsylvania will not be affected.
http://ir.inovio.com...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 16, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Collaborative Research Agreement, Research Collaboration, Dna-based Immunotherapy, Cancer  immunotherapy, Immunotherapy